7Baggers
Quarterly
Annual
    Unit: USD2025-09-26 2025-06-27 2025-03-28 2024-12-31 2024-09-27 2024-06-28 2024-03-29 2023-12-31 2023-09-29 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-07-01 2022-04-01 2021-12-31 2021-10-01 2021-07-02 2021-04-02 2020-12-31 2020-10-02 2020-07-03 2020-04-03 
      
    		                       
      cash flows from operating activities:
    		                       
      net income
    		-30,300,000 26,400,000 18,000,000 1,200,000 8,200,000 -1,151,600,000 23,600,000 -217,400,000 21,500,000 51,900,000 43,800,000 73,500,000 47,600,000 47,100,000 74,900,000 85,800,000 92,900,000 90,100,000 71,700,000 108,400,000 35,600,000 -93,500,000 -17,200,000 
      noncash items:
    		                       
      depreciation
    		10,100,000 10,800,000 9,100,000 9,200,000 10,500,000 11,600,000 9,500,000 9,200,000 8,900,000 9,400,000 8,500,000 7,900,000 7,800,000 8,300,000 7,800,000 11,400,000 9,500,000 9,600,000 10,300,000 10,900,000 11,900,000 10,100,000 9,500,000 
      amortization
    		19,100,000 19,000,000 18,800,000 18,600,000 18,700,000 22,400,000 22,600,000 23,700,000 23,900,000 24,100,000 27,900,000 27,800,000 27,900,000 26,800,000 23,500,000 20,200,000 20,600,000 21,000,000 21,000,000 22,200,000 22,700,000 22,800,000 22,500,000 
      allowance for credit losses
    		2,000,000 2,700,000 1,300,000 1,900,000 2,200,000 9,300,000 4,500,000 3,600,000 300,000 1,200,000 2,000,000 1,000,000 200,000 1,900,000 1,700,000 1,400,000 600,000 700,000 2,900,000     
      stock-based compensation expense
    		10,400,000 9,700,000 7,100,000 9,200,000 9,800,000 5,300,000 11,000,000 4,500,000 6,000,000 5,200,000 15,000,000 7,400,000 7,300,000 8,300,000 7,500,000 6,600,000 7,300,000 7,900,000 6,400,000 5,900,000 5,000,000 5,700,000 6,000,000 
      gain on investments in rabbi trust
    		-1,400,000                       
      loss on equity investments
    		                       
      loss on sale of property, plant and equipment
    		0                       
      goodwill and intangible asset impairments
    		   0 0                   
      fixed assets impairments and other charges
    		800,000   0 0                   
      non-cash operating lease costs
    		8,600,000 8,800,000 8,400,000 8,300,000 8,100,000                   
      amortization of debt discount and issuance costs
    		1,000,000 1,100,000 1,100,000 1,200,000 1,400,000 1,100,000 1,200,000 1,200,000 1,300,000 1,100,000 1,000,000 1,100,000 1,000,000 1,000,000 1,000,000 5,700,000 5,600,000 5,800,000 6,200,000 5,400,000 5,300,000   
      deferred income taxes
    		26,300,000   17,800,000 -700,000                   
      change in trade accounts receivable
    		13,600,000 -15,900,000 -21,300,000 10,900,000 -6,000,000 21,400,000 -16,300,000 16,000,000 -9,000,000 -15,500,000 -8,500,000 5,500,000 -19,900,000 -40,400,000 -16,200,000 -28,100,000 -13,600,000 3,600,000 -5,100,000 7,600,000 -61,800,000 53,100,000 73,000,000 
      change in inventories
    		-11,100,000 -13,400,000 -10,100,000 15,200,000 -600,000 1,200,000 -12,200,000 25,700,000 13,300,000 3,200,000 -7,100,000 -4,000,000 -6,400,000 -9,200,000 -20,300,000 1,100,000 -19,200,000 -27,500,000 -20,400,000 -4,900,000 26,200,000 27,300,000 -36,700,000 
      change in trade accounts payable
    		-15,900,000 5,100,000 -15,100,000 6,300,000 -2,500,000 -2,300,000 -2,700,000 6,900,000 -6,100,000 -9,000,000 -38,100,000 33,200,000 5,400,000 8,400,000 -2,500,000 19,600,000 -16,400,000 4,100,000 -27,600,000 70,900,000 27,800,000 -66,400,000 -10,700,000 
      change in prepaid expenses and other assets
    		5,800,000 3,500,000 -7,800,000 6,200,000 -9,200,000 100,000 -3,800,000 -2,100,000 6,500,000 -2,400,000 1,300,000 10,000,000 -4,300,000 -600,000 -16,800,000 11,900,000 -16,200,000 700,000 -7,900,000 31,300,000 -30,800,000 -14,400,000 11,400,000 
      change in accrued expenses and other liabilities
    		50,500,000 43,700,000 800,000 35,000,000 42,800,000 52,400,000 4,300,000 14,100,000 1,100,000 14,100,000 -41,300,000 -23,300,000 -28,800,000 -29,400,000 -51,500,000 53,000,000 15,500,000 3,700,000 -37,900,000 10,800,000 90,000,000 28,000,000 -118,800,000 
      change in operating lease liabilities
    		-10,600,000 -11,400,000 -10,800,000 -11,300,000 -11,400,000 -10,800,000 -9,300,000 -8,900,000 -8,800,000 -8,500,000 -8,300,000 -8,200,000 -7,900,000 -7,500,000 -8,000,000 -8,400,000 -8,400,000 -8,600,000 -12,100,000 -9,500,000 -9,100,000 -9,000,000 -9,100,000 
      net cash from operating activities
    		78,700,000 88,700,000 300,000 132,400,000 70,700,000 93,100,000 40,300,000 102,000,000 95,500,000 75,100,000 3,100,000 110,300,000 46,700,000 22,200,000 3,500,000 136,000,000 88,300,000 120,700,000 16,600,000 193,400,000 148,100,000 4,700,000 -62,300,000 
      cash flows from investing activities:
    		                       
      payments for additions to property, plant and equipment
    		-10,800,000 -12,300,000 -5,900,000 -8,600,000 -7,400,000 -6,800,000 -11,000,000 -8,200,000 -18,400,000 -14,100,000 -17,500,000 -16,900,000 -26,900,000 -12,100,000 -19,800,000 -8,700,000 -17,500,000 -20,200,000 -8,300,000 -13,100,000 -13,200,000 -7,800,000 -13,600,000 
      purchases of investments held in rabbi trust
    		-8,600,000 -300,000 -700,000 -200,000                    
      proceeds from sale of investments held in rabbi trust
    		9,000,000 200,000 700,000 500,000                    
      proceeds from sales of property, plant and equipment
    		0 0 500,000         1,700,000    0        
      proceeds from sale of equity investment
    		   0 0   0 0               
      all other investing activities
    		700,000 -4,700,000 -3,400,000 -1,700,000 600,000 500,000 300,000 -11,000,000 -7,700,000 600,000 -4,500,000 -100,000 -4,900,000 -8,500,000 -5,100,000 -13,100,000 2,800,000 2,900,000 2,800,000 2,700,000 3,600,000 3,900,000 3,800,000 
      net cash from investing activities
    		-9,700,000 -17,100,000 -8,800,000 -7,400,000 -30,600,000 -5,900,000 -10,700,000 -12,600,000 -25,000,000 -2,800,000 -22,000,000 -1,100,000 -69,700,000 -591,600,000 5,100,000  -3,100,000 -17,300,000 -5,500,000 -5,100,000 -9,600,000 -3,000,000 -51,400,000 
      cash flows from financing activities:
    		                       
      proceeds from stock option exercises
    		1,000,000 700,000 800,000 400,000 100,000 600,000 1,300,000 3,800,000 1,600,000 1,300,000 4,600,000 1,900,000 4,500,000 2,300,000 13,100,000 3,500,000 2,200,000 8,500,000 5,300,000 5,100,000 3,700,000 1,700,000 3,300,000 
      cash paid for treasury stock
    		-42,000,000 -85,700,000 -14,600,000                     
      tax withholding payment related to net settlement of equity awards
    		-700,000 -500,000 -3,800,000 -1,300,000 -600,000 -100,000 -3,300,000 -100,000 -1,400,000 -300,000 -6,100,000 -200,000 -800,000 -500,000 -7,600,000         
      repayment of convertible notes due 2025
    		0                       
      repayment of borrowings
    		   0    0      0 -500,000 0 -100,000 -100,000 -475,500,000   0 -100,000 
      proceeds from revolving line of credit
    		0           0        0 0   
      all other financing activities
    		   0 0 -200,000 -600,000 -100,000 -1,400,000       -1,700,000 -6,400,000 0 1,000,000 -1,300,000 1,700,000 -6,600,000 5,500,000 
      net cash from financing activities
    		-41,700,000 -86,400,000 -17,600,000 -900,000 -100,500,000 300,000 -2,600,000 3,300,000 114,500,000 2,600,000 -1,500,000 -68,300,000 73,700,000 1,800,000 5,300,000 1,800,000 -4,300,000 6,500,000 -469,600,000    258,500,000 
      effect of exchange rate changes on cash and cash equivalents
    		-4,000,000 48,100,000 34,300,000 -46,300,000 15,500,000 200,000 -18,500,000 23,100,000 -12,500,000 -8,400,000 -1,300,000 -2,500,000 -5,300,000 12,400,000 -9,200,000 8,400,000 4,000,000       
      net change in cash and cash equivalents
    		23,300,000 33,300,000 8,200,000 77,800,000 -44,900,000 87,700,000 8,500,000 115,800,000 172,500,000 66,500,000 -21,700,000 38,400,000 45,400,000 -555,200,000 4,700,000 434,800,000 84,900,000       
      beginning balance of cash and cash equivalents
    		0 0 1,069,100,000 0 0 0 940,000,000 0 0 0 606,900,000 0 0 0 1,073,600,000 0 0       
      ending balance of cash and cash equivalents
    		23,300,000 33,300,000 1,077,300,000 77,800,000 -44,900,000 87,700,000 948,500,000 115,800,000 172,500,000 66,500,000 585,200,000 38,400,000 45,400,000 -555,200,000 1,078,300,000 434,800,000 84,900,000       
      supplemental data:
    		                       
      cash paid for interest
    		4,000,000 9,700,000 13,400,000 9,300,000 15,900,000 12,800,000 16,700,000 15,300,000 12,600,000 21,000,000 14,300,000 17,300,000 7,300,000 11,000,000 2,800,000   11,600,000 10,500,000 22,400,000 17,500,000 13,900,000 2,900,000 
      cash paid for taxes
    		20,900,000 16,400,000 5,200,000 3,100,000 13,900,000 12,100,000 3,800,000 49,100,000 16,000,000 26,900,000 6,600,000 39,000,000   14,100,000   45,400,000 5,700,000 6,300,000 8,100,000 3,600,000 10,600,000 
      rou assets obtained in exchange for operating lease obligations
    		15,600,000 7,800,000 1,200,000 10,300,000 25,000,000 8,000,000 11,500,000 3,200,000 6,800,000 4,500,000 7,600,000 6,400,000   7,100,000   8,200,000 2,600,000 12,100,000 11,700,000 3,500,000 800,000 
      restructuring charges
    		 0 200,000    -200,000 600,000 -100,000 700,000 100,000 -800,000 1,700,000 5,700,000 -1,900,000 10,500,000 0   0 2,100,000   
      loss on investments in rabbi trust
    		  600,000                     
      treasury stock purchases in accrued liabilities
    		  4,300,000                     
      gain on equity investments
    		   -100,000 -600,000   0                
      gain on sale of property, plant and equipment
    		       -3,400,000    -800,000 0   0        
      gain on sale of kavo treatment unit and instrument business
    		           0 0 -2,900,000 -6,000,000         
      fair value adjustment of acquisition-related inventory
    		                       
      inducement expense related to exchange of convertible notes
    		       0                
      acquisitions, net of cash acquired
    		                   0 0 900,000 -41,600,000 
      proceeds from sale of kavo treatment unit and instrument business
    		           14,100,000 31,000,000 -1,200,000 30,000,000         
      proceeds from the settlement of derivative financial instruments
    		       500,000    100,000            
      proceeds from issuance of convertible notes due 2028
    		       0                
      debt issuance costs related to issuance of convertible notes due 2028
    		       -300,000                
      principal paid related to exchange of convertible notes due 2025
    		       0                
      proceeds from borrowings
    		       0      0 300,000        249,800,000 
      debt issuance costs related to other borrowings
    		       0                
      repayment of revolving line of credit
    		           -70,000,000        0    
      impairment charges
    		      800,000  100,000 -100,000 300,000 600,000 900,000 1,000,000 3,900,000 9,000,000 5,300,000 2,200,000 1,900,000 15,500,000 6,800,000   
      amortization of right-of-use assets
    		      7,300,000 7,100,000 6,800,000 6,600,000 6,500,000 6,600,000 6,500,000 4,800,000 6,400,000 7,000,000 7,000,000 7,100,000 7,200,000 7,400,000 7,900,000 7,400,000 7,800,000 
      other impairment charges
    		                       
      change in deferred income taxes
    		                       
      gain on sale of equity investment
    		                       
      proceeds from borrowing
    		           0            
      repayment of borrowing
    		           0            
      proceeds from issuance of convertible senior notes
    		                   0 0   
      payment of debt issuance and other deferred financing costs
    		               0 0 -1,900,000 -400,000 0 100,000   
      purchase of capped calls related to issuance of convertible senior notes
    		                   0 0   
      fair value of acquisition-related inventory
    		                       
      acquisition, net of cash acquired
    		            -126,400,000           
      net cash from (used) in investing activities
    		                       
      proceeds from the public offering of common stock, net of issuance costs
    		                       
      consideration to former parent in connection with the separation
    		                       
      net transfers to former parent
    		                       
      effect of exchange rate changes on cash and equivalents
    		                  10,800,000 -4,000,000 -15,700,000 -7,500,000 -2,400,000 
      net change in cash and equivalents
    		                  -447,700,000 188,100,000 -121,600,000 468,800,000 142,400,000 
      beginning balance of cash and equivalents
    		                  888,900,000 0 0 0 211,200,000 
      ending balance of cash and equivalents
    		                  441,200,000 188,100,000 -121,600,000 468,800,000 353,600,000 
      assets acquired:
    		                       
      cash
    		                  2,900,000   0 2,900,000 
      trade accounts receivable
    		                  1,000,000   0 1,000,000 
      inventories
    		                  1,900,000   0 1,900,000 
      prepaid expenses and other current assets
    		                  200,000   0 200,000 
      property, plant and equipment
    		                  500,000   0 500,000 
      goodwill
    		                  25,100,000   -800,000 25,200,000 
      other intangible assets
    		                  22,300,000   0 22,300,000 
      total assets acquired
    		                  53,900,000   -800,000 54,000,000 
      liabilities assumed:
    		                       
      trade accounts payable
    		                  -100,000   0 -100,000 
      accrued expenses and other liabilities
    		                  -10,200,000   0 -9,400,000 
      total liabilities assumed
    		                  -10,300,000   0 -9,500,000 
      total net assets acquired
    		                  43,600,000   -800,000 44,500,000 
      allowance for doubtful accounts
    		                    8,500,000   
      consideration to danaher in connection with the separation
    		                       
      net cash from in financing activities
    		                       
      net cash from (used) in financing activities
    		                       
      net transfers from former parent
    		                       
      restructuring and impairment charges
    		                       
      proceeds from borrowings, net of deferred costs
    		                       
      payment for purchase of noncontrolling interest and related transactions
    		                       
      category
    		                       
      buildings
    		                       
      leased assets and leasehold improvements
    		                       
      machinery and equipment
    		                       
      net earnings
    		                       
      net proceeds from borrowings
    		                       
      net transfers to parent
    		                       
      supplemental disclosures:
    		                       
      cash income tax payments
    		                       
      cash interest payments
    		                       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.